-
Dopamine neuronal replacement cell therapy can be beneficial for patients with advanced disease, and that changing technical approaches could have a favorable impact on efficacy and adverse events following neural transplantation.
-
Introduction of HAART has dramatically modified the natural history of HIV disease by controlling viral replication, but, in turn, lengthening of the survival of HIV-infected individuals has been associated with an increasing prevalence of iatrogenic conditions.
-
Normal circulating plasma glucose concentration is maintained by a delicate constant balance between glucose utilization (i.e., glycolysis or storage as glycogen by various tissues) on one hand and glucose production on the other (i.e., glycogenolysis and gluconeogenesis induced in certain tissues, such as liver, muscle, renal parenchyma, and adipose tissue). During the late post-absorptive period or starvation, normal glucose concentration is maintained by facilitating glucose production while inhibiting glucose uptake.
-
This study reports findings from a survey of 2,323 ICU nurses regarding their intention to leave due to working conditions and factors predicting this intention. The sample was part of a larger study of patient safety that involved 110 ICUs from 66 hospitals across the United States.
-
A systematic search of the literature from 1984 to 2004 was conducted in order to answer the question posed by the title of this article: How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia (HIT)?
-
Severe sepsis with organ failure has one of the highest mortality rates of any diagnosis commonly treated in the Intensive Care Unit. Recent clinical trials have provided some positive results with reductions in overall mortality from sepsis.
-
A previously described "closed-loop knowledge based system" placed into a standard ventilator may be used to guide weaning via the pressure support mode.
-
Antiaging Supplements Proven Ineffective; The Three Most Common Culprits of ADE; New Guidelines for Lyme Disease Prevention; FDA Actions
-
-
